Skip to main content

GORE® PROPATEN® Vascular Graft Above-knee bypass primary patency

GORE® PROPATEN® Vascular Graft Above-knee bypass primary patency

* Overall weighted average primary patency is based on data from 15 peer-reviewed publications meeting pre-determined inclusion criteria.

Study size (N) reflects the initial cohert size of the study.


Above-knee data

Study Year N Primary Patency      
      Year 1 Year 2 Year 3 Year 4 Year 5
Piffaretti et al 2018 360 82% 77.50% 74% 71% 64%
Samson et al 2016 87 92% 85% 85% 85% 85%
Lindholt et al 2011 112 81%        
Daenens et al 2009 86 92% 83%      
Peeters et al 2008 75 81% 78% 75%    
Bosiers et al 2006 55 84%        

Inclusion criteria

Inclusion criteria for above-knee fem-pop GORE® PROPATEN® Vascular Graft data used in this analysis:

  • Peer-reviewed clinical journal publications in English language
  • Non-overlapping patient populations
  • AK bypass primary patency reported for at least 12 months of follow-up
  • N = 50 or more AK fem-pop bypass in the GORE® PROPATEN® Vascular Graft    treatment arm
  • Data of analysis on file